Itera | $12,000,000 | (May 28, 2026)
ClearNote Health | $52,000,000 | (May 28, 2026)
Protuoso Biosciences | $9,500,000 | (May 28, 2026)
Certified by Founder
Lodge
Secretome Therapeutics
start up
United States
- Baltimore, Maryland
- 28/05/2026
- Series A
- $30,000,000
Secretome Therapeutics is a clinical-stage cell therapy company focused on orphan and underserved cardiac diseases. STM-01, the lead drug, is a neonatal cardiac progenitor cell (nCPC) isolated from cardiac tissue excised during life-saving, open-heart surgery on newborns with congenital heart defects. The main target indication for STM-01 is Duchenne muscular dystrophy-associated cardiomyopathy (DMD-CM).
- Industry Biotechnology Research
- Website https://secretometherapeutics.com/
- LinkedIn https://www.linkedin.com/company/secretometx/
Fields Good | $1,800,000 | (May 28, 2026)
Cypher AI | $2,000,000 | (May 28, 2026)
C2i Semiconductors | $16,700,000 | (May 28, 2026)
Certo | $4,000,000 | (May 28, 2026)
Mykor | $5,360,920 | (May 28, 2026)
Go Swag | $5,000,000 | (May 27, 2026)